Success Stories: A Postdoctoral Fellow Achieves EB1A Case Approval in 6 days only with the Help of Our Assistance, Also thanks to Premium Processing!
Client’s Testimonial:
“That is wonderful news!! Thank you so much. It has been absolutely great working with your team through this process! Thank you for all of your help with this application!”
On September 13th, 2023, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Fellow in the Field of Cancer Biology (Approval Notice).
General Field: Cancer Biology
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: India
State of Residence at the Time of Filing: Texas
Approval Notice Date: September 13th, 2023
Processing Time: 6 days (Premium Processing Requested)
Case Summary:
A postdoctoral fellow contacted our law firm to help her establish her significant contributions to the U.S. by filing for an EB-1A (Alien of Extraordinary Ability) petition. We presented her exceptional professional background and unparalleled experience important to her current and future work at the USCIS.
Upon reviewing her credentials, we found that our client is a Ph.D. in cell, molecular, and cancer biology and has accomplished a great publication record in her field. Her research resulted in:
- 9 peer-reviewed scientific articles and 1 pre-print, these papers have been published in some of the most discerning, high-impact journals in the field of cancer biology.
- She has conducted at least 18 reviews for journals to date and her work has been cited by other scholars in numerous published articles as well.
- According to Google Scholar, her work has been cited 302 times in at least 30 countries.
Furthermore, her research on ovarian and colon cancer and the mechanisms of chemoresistance and inflammation addresses some of our nation’s and the world’s most pressing issues, including the lack of effective treatments for ovarian and colon cancer due to the development of platinum resistance, the need for growth in the medical literature on cancer pathogenesis, development, and management, and the strain on national healthcare and economic resources due to these cancers.
Her strong background in cancer metastasis, tumorigenesis, and chemoresistance, combined with her technical skills in RNA sequencing, quantitative PCR, in vitro modeling, and other methods of biological experimentation, have allowed her research to be particularly original, resulting in her success in fundamentally transforming ovarian and colon cancer research.
Her case was further supported by including four recommendation letters that she obtained from her fellow experts in the field. One of the recommenders stated:
“…[Client’s] remarkable academic accomplishments with regard to cancer are benefitting other researchers in the field and accelerating developments in treatment…[Client] is orchestrating essential work to improve the survival of patients with this cancer. She is one of the best researchers in the field of cancer biology …As chemotherapy is a predominant treatment for serious cancers, [client] discoveries are crucial for the American healthcare industry.”
Our team’s efforts successfully paid off in conveying to the USCIS that our client’s impressive background, strong record of past achievements, recognition of expertise by journals seeking her services to review manuscripts, and unique knowledge relevant to her current and future work indicate not only that she qualifies as an alien of extraordinary ability but also that her entry will substantially benefit prospectively the United States.
We would like to congratulate her on securing EB1A approval and thanks to the Premium Processing service, she received her approval in only 6 days. We wish her to receive her green card as soon as possible.